Lars Minor
Chief Executive Officer at NEWBURY PHARMACEUTICALS AB
Profile
Lars Minor is currently the Chief Executive Officer at Newbury Pharmaceuticals AB since 2021.
Prior to this, he worked as the Vice President-Strategy & Execution at LEO Pharma A.
Mr. Minor completed his undergraduate degree from Copenhagen Business School.
Lars Minor active positions
Companies | Position | Start |
---|---|---|
NEWBURY PHARMACEUTICALS AB | Chief Executive Officer | 31/12/2020 |
Former positions of Lars Minor
Companies | Position | End |
---|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
Training of Lars Minor
Copenhagen Business School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NEWBURY PHARMACEUTICALS AB | Health Technology |
Private companies | 1 |
---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
- Stock Market
- Insiders
- Lars Minor